Ledger.Open graph →
SEC Form D · filed November 3, 2023

Centerline Biomedical, Inc

Offering
$34.7M
Sold
$34.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CLEVELAND, OH
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Akhil Saklecha · Cleveland, OHDirectorPhil N. Rackliffe · Cleveland, OHExec · DirectorVinod K. Goel · Cleveland, OHExecGulam Khan · Cleveland, OHExecVikash K. Goel · Cleveland, OHExecJonathan P. Michael · Menlo Park, CADirectorGulam Khan · Cleveland, OHExecVikash K. Goel · Cleveland, OHExecPhil N. Rackliffe · Cleveland, OHExec · DirectorVinod K. Goel · Cleveland, OHExecTodd Schwarzinger · Cleveland, OHDirectorMitch Wolf · Cleveland, OHDirectorChristopher Mclaughlin · Chicago, ILDirectorJames R. Mccaffrey · Alpharetta, GAExecEdward C. Copelin · Alpharetta, GAExecJacob Claver · CANTON, TXExecYaron C. Ashkenazi · Scottsdale, AZExec · DirectorTodd Schwarzinger · Cleveland, OHDirectorMitch Wolf · Cleveland, OHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗